HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+8.39%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.47B
AUM Growth
+$2.47B
(+3.4%)
Cap. Flow
-$13.7M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
55.01%
Holding
63
New
13
Increased
17
Reduced
8
Closed
25
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$151M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$108M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$91.6M |
| 4 |
UnitedHealth
UNH
|
$87.8M |
| 5 |
Cooper Companies
COO
|
$81.4M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$145M |
| 2 |
Labcorp
LH
|
$92M |
| 3 |
Cigna
CI
|
$88.6M |
| 4 |
Encompass Health
EHC
|
$77.2M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$74.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stryker
SYK
$149B
| $24.7M | 0.99% |
+118,550
| New | +$24.7M |
|
27
Edwards Lifesciences
EW
$47.7B
| $17.9M | 0.72% |
+223,860
| New | +$17.9M |
|
28
Zymeworks
ZYME
$1.07B
| $16.1M | 0.64% |
+345,550
| New | +$16.1M |
|
29
Assembly Biosciences
ASMB
$183M
| $8.54M | 0.34% |
+43,291
| New | +$8.54M |
|
30
Bristol-Myers Squibb
BMY
$96.7B
| $7.57M | 0.3% |
125,500
-937,000
| -88% | -$56.5M |
|
31
American Well
AMWL
$112M
| $7.41M | 0.3% |
+12,500
| New | +$7.41M |
|
32
Align Technology
ALGN
$9.59B
| $4.81M | 0.19% |
14,680
-34,610
| -70% | -$11.3M |
|
33
Athira Pharma
ATHA
$15.5M
| $4.02M | 0.16% |
+217,500
| New | +$4.02M |
|
34
Dyne Therapeutics
DYN
$1.92B
| $2.42M | 0.1% |
+120,000
| New | +$2.42M |
|
35
Incyte
INCY
$17B
| $2.03M | 0.08% |
+22,580
| New | +$2.03M |
|
36
Outset Medical
OM
$245M
| $1.75M | 0.07% |
+2,333
| New | +$1.75M |
|
37
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.11M | 0.04% |
+14,600
| New | +$1.11M |
|
38
Syndax Pharmaceuticals
SNDX
$1.39B
| $475K | 0.02% |
+32,200
| New | +$475K |
|
39
Abbott
ABT
$230B
| – | – |
-638,180
| Closed | -$58.3M |
|
40
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-1,025,000
| Closed | -$49.7M |
|
41
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-345,370
| Closed | -$16.7M |
|
|
42
Becton Dickinson
BDX
$54.3B
| – | – |
-621,632
| Closed | -$145M |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| – | – |
-20,126
| Closed | -$15.9M |
|
44
BioNTech
BNTX
$24.1B
| – | – |
-503,920
| Closed | -$33.6M |
|
|
BPMC
45
DELISTED
Blueprint Medicines
BPMC
| – | – |
-743,018
| Closed | -$58M |
|
|
46
Cigna
CI
$80.2B
| – | – |
-472,360
| Closed | -$88.6M |
|
|
47
Encompass Health
EHC
$12.5B
| – | – |
-1,566,749
| Closed | -$77.2M |
|
48
Generation Bio
GBIO
$40.3M
| – | – |
-10,000
| Closed | -$2.1M |
|
49
Legend Biotech
LEGN
$6.64B
| – | – |
-75,000
| Closed | -$3.19M |
|
|
50
Labcorp
LH
$22.8B
| – | – |
-644,868
| Closed | -$92M |
|